JPWO2022212700A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022212700A5 JPWO2022212700A5 JP2023560496A JP2023560496A JPWO2022212700A5 JP WO2022212700 A5 JPWO2022212700 A5 JP WO2022212700A5 JP 2023560496 A JP2023560496 A JP 2023560496A JP 2023560496 A JP2023560496 A JP 2023560496A JP WO2022212700 A5 JPWO2022212700 A5 JP WO2022212700A5
- Authority
- JP
- Japan
- Prior art keywords
- lys
- 1peg2
- substituted
- pharma
- solvate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163169545P | 2021-04-01 | 2021-04-01 | |
| US63/169,545 | 2021-04-01 | ||
| US202263325328P | 2022-03-30 | 2022-03-30 | |
| US63/325,328 | 2022-03-30 | ||
| PCT/US2022/022817 WO2022212700A2 (en) | 2021-04-01 | 2022-03-31 | Conjugated hepcidin mimetics |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2024513391A JP2024513391A (ja) | 2024-03-25 |
| JP2024513391A5 JP2024513391A5 (https=) | 2025-03-06 |
| JPWO2022212700A5 true JPWO2022212700A5 (https=) | 2025-03-06 |
| JP7849383B2 JP7849383B2 (ja) | 2026-04-21 |
Family
ID=83459967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023560496A Active JP7849383B2 (ja) | 2021-04-01 | 2022-03-31 | コンジュゲートされたヘプシジン模倣物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240209053A1 (https=) |
| EP (1) | EP4314014A4 (https=) |
| JP (1) | JP7849383B2 (https=) |
| AU (1) | AU2022249097A1 (https=) |
| CA (1) | CA3214153A1 (https=) |
| TW (1) | TW202304952A (https=) |
| WO (1) | WO2022212700A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2968443T3 (da) | 2013-03-15 | 2021-12-06 | Protagonist Therapeutics Inc | Hepcidinanaloger og anvendelser deraf |
| PT3143037T (pt) | 2014-05-16 | 2021-09-24 | Protagonist Therapeutics Inc | Antagonistas peptídicos tioéter de integrina alfa4beta7 |
| US9624268B2 (en) | 2014-07-17 | 2017-04-18 | Protagonist Therapeutics, Inc. | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases |
| EP3749345A4 (en) | 2018-02-08 | 2022-04-06 | Protagonist Therapeutics, Inc. | CONJUGATED HEPCIDIN MIMETICS |
| AU2021209086A1 (en) | 2020-01-15 | 2022-08-04 | Janssen Biotech, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| AU2021383828A1 (en) | 2020-11-20 | 2023-07-06 | Janssen Pharmaceutica Nv | Compositions of peptide inhibitors of interleukin-23 receptor |
| WO2023288019A2 (en) | 2021-07-14 | 2023-01-19 | Janssen Biotech, Inc. | Lipidated peptide inhibitors of interleukin-23 receptor |
| EP4472995A4 (en) * | 2022-02-02 | 2025-11-19 | Protagonist Therapeutics Inc | Conjugated hepcidin mimetics |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7192713B1 (en) | 1999-05-18 | 2007-03-20 | President And Fellows Of Harvard College | Stabilized compounds having secondary structure motifs |
| US20040152868A1 (en) * | 2001-03-30 | 2004-08-05 | Larsen Bjarne Due | Compositions and methods for modulating guanylyl cyclase signaling receptor (gc-c) activity and for treating meniere's disease |
| WO2007093013A1 (en) | 2006-02-17 | 2007-08-23 | Monash University | Methods for the synthesis of dicarba bridges in organic compounds |
| CN102245626A (zh) * | 2008-12-05 | 2011-11-16 | 加利福尼亚大学董事会 | 微型铁调素肽及其使用方法 |
| US9624268B2 (en) * | 2014-07-17 | 2017-04-18 | Protagonist Therapeutics, Inc. | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases |
| US20190002503A1 (en) * | 2015-12-30 | 2019-01-03 | Protagonist Therapeutics, Inc. | Analogues of hepcidin mimetics with improved in vivo half lives |
| EP3749345A4 (en) * | 2018-02-08 | 2022-04-06 | Protagonist Therapeutics, Inc. | CONJUGATED HEPCIDIN MIMETICS |
-
2022
- 2022-03-31 CA CA3214153A patent/CA3214153A1/en active Pending
- 2022-03-31 WO PCT/US2022/022817 patent/WO2022212700A2/en not_active Ceased
- 2022-03-31 AU AU2022249097A patent/AU2022249097A1/en active Pending
- 2022-03-31 EP EP22782209.5A patent/EP4314014A4/en active Pending
- 2022-03-31 US US18/285,198 patent/US20240209053A1/en active Pending
- 2022-03-31 JP JP2023560496A patent/JP7849383B2/ja active Active
- 2022-04-01 TW TW111112896A patent/TW202304952A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11753443B2 (en) | Conjugated hepcidin mimetics | |
| JPWO2022026629A5 (https=) | ||
| JP2026012422A (ja) | コンジュゲート型ヘプシジン模倣体 | |
| JP7849383B2 (ja) | コンジュゲートされたヘプシジン模倣物 | |
| JP2012530145A5 (https=) | ||
| RU2013154047A (ru) | Пептидные лекарственные препараты с повышенной эффективностью против инсулинорезистентности | |
| JP2009532384A5 (https=) | ||
| JPWO2022026631A5 (https=) | ||
| WO2017117411A1 (en) | Analogues of hepcidin mimetics with improved in vivo half lives | |
| AU2022249095A1 (en) | Conjugated hepcidin mimetics | |
| WO2022212698A1 (en) | Conjugated hepcidin mimetics | |
| JP2024520861A (ja) | 遺伝性ヘモクロマトーシスの治療のためのヘプシジン模倣体 | |
| JP2009532385A5 (https=) | ||
| CN109106942B (zh) | 一种可通过血脑屏障的多肽在制备药物中的应用 | |
| JPWO2022212700A5 (https=) | ||
| JPWO2022212696A5 (https=) | ||
| JPWO2020120984A5 (https=) | ||
| CN109265558B (zh) | 改进型齐考诺肽在制备药物中的应用 | |
| AR125266A1 (es) | Miméticos de hepcidina conjugados | |
| EA053112B1 (ru) | Конъюгированные миметики гепсидина | |
| AR125265A1 (es) | Miméticos de hepcidina conjugados | |
| CN117813313A (zh) | 结合型铁调素模拟物 | |
| CN117480176A (zh) | 用于治疗遗传性血色病的铁调素模拟物 | |
| CN117730089A (zh) | 结合型铁调素模拟物 | |
| NZ822560B2 (en) | Novel triple glp-1/gip/glucagon receptor agonist and a pharmaceutical composition for preventing or treating obesity comprising the same |